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Abstract
Pulmonary edema associated with increased vascular permeabil-
ity is a severe complication of Staphylococcus aureus–induced
sepsis and an important cause of human pathology and death.We
investigated the role of the mammalian acid sphingomyelinase
(Asm)/ceramide system in the development of lung edema
caused by S. aureus. Our findings demonstrate that genetic
deficiency or pharmacologic inhibition of Asm reduced lung
edema in mice infected with S. aureus. The Asm/ceramide
system triggered the formation of superoxide, resulting in degra-
dation of tight junction proteins followed by lung edema.
Treatment of infected mice with amitriptyline, a potent inhibitor
of Asm, protected mice from lung edema caused by S. aureus,
but did not reduce systemic bacterial numbers. In turn, treatment
with antibiotics reduced bacterial numbers but did not protect
mice from lung edema. In contrast, only the combination of
antibiotics and amitriptyline inhibited both pulmonary edema
and bacteremia protecting mice from lethal sepsis and lung
dysfunction suggesting the combination of both drugs as novel
treatment option for sepsis.
Key messages
& Antibiotics are often insufficient to cure S. aureus–in-
duced sepsis.
& S. aureus induces lung edema via the Asm/ceramide
system.
& Genetic deficiency of Asm inhibits lung dysfunction upon
infection with S. aureus.
& Pharmacologic inhibition of Asm reduces lung edema
induced by S. aureus.
& Antibiotics plus amitriptyline protect mice from lung ede-
ma and lethal S. aureus sepsis.
Keywords Acid sphingomyelinase/ceramide system . Lung
edema . Superoxide . Staphylococcus aureus
Introduction
Although Staphylococcus aureus (S. aureus) is a commensal
of the skin, it is also one of the most serious pathogens and
often causes not only local purulent wound infections of the
skin and soft tissues but also severe diseases such as pneumo-
nia, endocarditis, osteomyelitis, sepsis, and toxic shock syn-
drome [1, 2]. In particular, the methicillin-resistant S. aureus
(MRSA) strains are increasing in importance, particularly in
hospitals [3, 4]. In the United States, S. aureus is responsible
for approximately 500,000 infections and 20,000 deaths each
year [5]. A dreaded complication of S. aureus–induced sepsis
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is lung edema, which is often fatal. Damage to the endotheli-
um and disruption of tight junctions (TJs) are central to the
pathophysiology of lung edema and sepsis after systemic
infection with S. aureus [6, 7].
It has been previously shown that the interaction of S. aureus
with endothelial cells depends on the activation of mammalian
acid sphingomyelinase (Asm) [8]. The Asm is an ubiquitous
enzyme, which is expressed in all cells including myeloid cells
[9]. Asm hydrolyzes sphingomyelin, which is the most promi-
nent sphingolipid in the membrane, to ceramide [10]. Ceramide
has been shown to spontaneously form distinct domains in the
plasma membrane leading to the formation of ceramide-rich
platforms. Those platforms serve to trap and cluster receptor
molecules, thereby permitting and amplifying signal transduction
[11, 12]. This process may lead to subsequent apoptosis of the
endothelial cells upon infection with S. aureus. However, several
other pathogens besides S. aureus, such as Neisseria
gonorrhoeae, Listeria monocytogenes, Pseudomonas
aeruginosa, Salmonella typhimurium, Escherichia coli, and
Mycobacterium avium, also exploit the Asm/ceramide system
to infect mammalian cells [13–18]. The Asm/ceramide system
has been shown to be involved in internalization of these path-
ogens, the induction of host cell apoptosis, the activation of
intracellular signaling pathways, and the control of the release
of cytokines.
The Asm/ceramide system is also crucially involved in
killing bacteria, predominantly by facilitating the activation
of NADPH oxidases. Ceramide domains cluster subunits of
NADPH oxidases, thereby releasing superoxide after the in-
fection of macrophages [19]. Although superoxide is neces-
sary for killing bacteria, the results of previous studies also
indicate that superoxide molecules contribute to S. aureus–
induced dysfunction of the lung endothelial cell barrier [20].
The family of NADPH oxidases appears to be the predomi-
nant contributor of endothelial superoxide, which is activated
by several stimuli and involved in diverse pathways, including
endothelial cell activation and inflammation [21].
Here, we investigated the role of Asm in S. aureus–induced
lung edema. Our findings provide evidence that the Asm/
ceramide system plays a central role in S. aureus–induced pul-
monary edema via induction of superoxide and thereby destruc-
tion of TJ proteins. Genetic or pharmacologic inhibition of Asm
or production of superoxide reduced lung injury after S. aureus
infection. Pharmacologic inhibition of Asm with amitriptyline, a
functional inhibitor of the enzyme, inhibited lung edema but did
not reduce bacterial numbers in mice infected with S. aureus.
Antibiotics reduced bacterial numbers but did not protect mice
from lung edema, a finding consistent with the clinical observa-
tion that patients with S. aureus sepsis experience severe lung
edema despite treatment with antibiotics. Treating infected mice
with a combination of antibiotics and amitriptyline reduced both
pulmonary edema and bacteremia, thus protecting mice from
lethal sepsis and lung dysfunction.
Materials and methods
Mice and cells
Ac i d - sph i ngomye l i n a s e (Asm) -de f i c i en t m i c e
(sphingomyelin phosphodiesterase 1 knockout; Smpd1−/−)
and syngenic wild-type (wt) littermates on a C57BL/6J genet-
ic background were kindly provided by Dr. R. Kolesnick
(Memorial Sloan-Kettering Cancer Center, New York, NY,
USA). Mice were maintained in the animal facility of the
University Duisburg-Essen under pathogen-free conditions
according to the criteria of the Federation of Laboratory
Animal Science. The genotype was verified by PCR analysis
before experimentation. For all experiments, we used mice
only aged 6 to 8 weeks, which do not show an accumulation of
myeloid cells, mostly macrophages, in the lung (Fig. 1c, non-
infected sample). Further, the concentrations of TNF-α and
IL-1 did not differ in lungs of 6-week-old wt and Asm-
deficient mice (not shown). Infection experiments were ap-
proved by the Landesamt für Natur, Umwelt und
Verbraucherschutz (LANUV), animal grant G1376/13 and
local authorities.
For pretreatment with inhibitors before infection, wt mice
were injected intraperitoneally with 10 mg/kg amitriptyline
(Sigma-Aldrich, Deisenhofen, Germany), 100 mg/kg Tiron
(Fluka Chemie GmbH, Buchs, Germany), or 100 mg/kg
NAC (Sigma) twice daily for 2.5 days. The last dose was
given 1 h before infection. For treatment with amitriptyline
post infection, wt mice were injected i.p. 1 or 2 h after
infection with 16 mg/kg amitriptyline. Antibiotics were also
injected i.p. 1 h after infection with 100 mg/kg methicillin
(Sigma) or 100 mg/kg vancomycin (Sigma). The injection of
methicillin or vancomycin was repeated 9 h after infection. All
mice, either pretreated with inhibitors or post-treated with
amitriptyline and/or antibiotics, were sacrificed after 12 or
24 h. For survival experiments, we administered 16 mg/kg
amitriptyline 1 h after infection and reduced to 10 mg/kg
amitriptyline in the following injection after 12 h and then
twice daily until 144 h post-infection. The antibiotics vanco-
mycin and methicillin were administered twice daily
(100 mg/kg), starting 12 and 24 h after infection until 144 h
post-infection.
The in vitro experiments were performed with murine
EOMA endothelial cells (ATCC® CRL-2586™), which
were maintained in Dulbecco’s modified Eagle’s medi-
um (DMEM) (Gibco/Invitrogen, Karlsruhe, Germany)
supplemented with 10 % fetal calf serum (PAA,
Pasching, Austria, A15-101), 10 mM HEPES (Roth
GmbH, Karlsruhe, Germany), pH 7.4, 2 mML-gluta-
mine, 1 mM sodium pyruvate, 100 μM non-essential amino
acids, 100 U/ml penicillin, and 100 μg/ml streptomycin (all
from Thermo Fisher Scientific, Waltham, USA) at 37 °C in a
10 % CO2 atmosphere.
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Infection experiments
All in vivo and in vitro infections were performed with a
clinical S. aureus strain isolated from a patient with sepsis.
Further characterization of the strain showed that it produces
alpha-toxin and enterotoxin D but not the Panton-Valentine
leukocidin or toxic shock syndrome toxins. To exclude strain-
specific results, we repeated the principal experiments with
the well-characterized S. aureus sepsis strain Newman
(ATCC® 25904) [43].
Bacteria were grown overnight on trypticase soy agar
plates supplemented with 5 % sheep blood (BD Biosciences,
Heidelberg, Germany). The plates were incubated for 16 h at
37 °C. Bacteria were then resuspended in prewarmed
trypticase soy broth (TSB; BD) at an optical density
(550 nm) of 0.2/ml, shaken at 125 rpm for 70 min at 37 °C,
and collected during the early logarithmic growth phase by
centrifugation at 3000 rpm for 10min. The bacterial pellet was
washed twice in DMEM supplemented with 10 mM HEPES
(Roth GmbH, Karlsruhe, Germany) or phosphate buffered
saline (PBS, 137 mM NaCl, 2.7 mM KCl, 7 mM CaCl2,
0.8 mM MgSO4, 1.4 mM KH2PO4, and 6.5 mM Na2HPO4)
and then resuspended at 9×108 colony-forming units (CFU)
per milliliter of DMEM supplemented with 10 mM HEPES
for infection of EOMA cells or at 5×106 CFU per 100 μl in
PBS for infection of mice.
EOMA cells were infected in DMEM/10 mM HEPES. We
added 20 μM amitriptyline, 10 mM Tiron, or 10 mM NAC
20 min before infection and inoculated sub-confluent cell
layers at a bacteria-to-host cell ratio (multiplicity of infection,
MOI) of 10:1 or 200:1. Synchronous infection conditions and
enhanced interactions between bacteria and host cells were
achieved by a 2-min centrifugation (1000 rpm) of the bacteria
onto the cells. The end of the centrifugation was defined as the
starting point of infection. The infection was terminated by
fixation or lysis, as described below.
To infect the mice, we intravenously injected 5×106 CFU
S. aureus. After the indicated time, the animals were sacrificed
by cervical dislocation, and the lung, spleen, or liver was
removed for further processing. To determine the amount of
Evans Blue leakage into lung tissue, we injected mice intra-
venously with 4 % Evans Blue dye (20 mg/kg, Sigma) 30 min
before sacrificing the mice (infection time 12 h); lungs were
flushed with saline via the right heart, removed, dried, extract-
ed in formamide (Sigma), centrifuged, and supernatants were
measured at 620 and 740 nm with a fluorescence microplate
reader (BMG Labtech, Offenburg, Germany). To determine
neutrophil immigration capacity, we infected mice with 5×
106 CFU S. aureus i.p. for 2 h, sacrificed them, and injected
ice-cold PBS into the peritoneal cavity. Peritoneum was then
gently massaged and PBS was aspirated from the peritoneal
cavity. The cell number was counted and 1 ml cell suspension
was preincubated with anti-CD16/CD32 mAb (Biolegend,
clone 93) to block FcRII/III receptors and stained for 15 min
at 4 °C with FITC-anti-mouse Ly-6G (Gr1) (eBioscience,
clone RB6-8C5), PE-Cy7-anti-mouse CD11b (eBioscience,
clone M1/70), and APC-anti-mouse F4/80 (eBioscience,
clone BM8). Cells were analyzed using FACS Calibur™
(BD Bioscience) and absolute numbers were calculated.
Assay for acid sphingomyelinase activity
The activity of Asm was measured as the conversion of
radioactive [14C]-sphingomyelin to ceramide and [14C]-
phosphorylcholine. Then 8×105 EOMA cells were infected
with S. aureus for the indicated time periods, washed, and
lysed in 300 μl ice-cold Asm lysis buffer [1 % NP-40,
250 mM sodium acetate (pH 5.0)] per sample, aliquots diluted
to 0.1 % NP-40 and 250 mM sodium acetate (pH 5.0), and
incubated with [14C]-sphingomyelin (Perkin Elmer, specific
activity=2 GBq/mmol) for 30 min at 37 °C. [14C]-
sphingomyelin was dried prior to use and solubilized into
micelles in 0.1 % NP-40, 250 mM sodium acetate (pH 5.0)
using a bath sonicator for 10 min. Samples were normalized
for protein using Bradford assays.
Cell lysates were incubated for 60min with 0.05μCi [14C]-
labeled sphingomyelin per sample at 37 °C with a
thermomixer (Eppendorf AG, Hamburg, Germany). Lipids
were then extracted by the addition of 1 ml CHCl3/CH3OH
(2:1, v/v) per sample, followed by vortexing for 15 s and
centrifugation at 14,000 rpm for 5 min. An aliquot of the
aqueous phase was applied for liquid scintillation counting.
Hydrolysis of [14C]-sphingomyelin by Asm results in the
release of [14C]-choline chloride into the aqueous phase,
whereas ceramide and unreacted [14C]-sphingomyelin remain
in the organic phase. Therefore, the release of [14C]-choline
chloride serves to determine the activity of Asm.
Ceramide measurements
Ceramide was measured using a DAG kinase assay, as previ-
ously described [15, 17]. Briefly, cells were infected for the
indicated time and then extracted in CHCl3/CH3OH/1 N HCl
(100:100:1, v/v/v). The organic phase was collected and dried
lipids were solubilized in 20 μl of 7.5 % N-octyl
glucopyranoside, 5 mM cardiolipin, 1 mM DETAPAC and
sonicated in a bath sonicator for 10 min. We then added 50 μl
DAG kinase reaction buffer [100 mM imidazole/HCl
(pH 6.6), 100 mM NaCl, 25 mM MgCl2, 2 mM EDTA,
2.8 mM DTT, 5 μM ATP, 10 μCi [32P]-γATP] and 0.01 U
DAG kinase (BML-SE100; Enzo Life Sciences, USA) in
10 μl of 1 mM DETAPAC (pH 6.6) and 0.01 M imidazole.
The kinase reaction was performed for 30 min at room
temperature.
The samples were then re-extracted in 1 ml CHCl3/
CH3OH/1 N HCl (100:100:1, v/v/v), 170 μl buffered salt
J Mol Med (2015) 93:675–689 677
solution [135 mM NaCl, 1.5 mM CaCl2, 0.5 mM MgCl2,
5.6 mM glucose, 10 mM HEPES (pH 7.2)], and 30 μl of a
100 mM EDTA solution per sample, followed by vortexing.
The lower organic phase was concentrated, and dried lipids
were dissolved in 20 μl CHCl3/CH3OH (1:1, v/v) per sample
and separated on a Silica G60 thin layer chromatography
(TLC) plate (Merck, Darmstadt, Germany) with a solvent
system consisting of CHCl3/CH3COCH3/CH3OH/
CH3COOH/H2O (10:4:3:2:1, v/v/v/v/v). The plate was ana-
lyzed using a Fuji phosphoimager. Ceramide spots were iden-
tified by co-migration with a C16/C24-ceramide standard.
Comparison with a standard curve for C16/C24-ceramide per-
mitted the determination of ceramide amounts.
To determine local accumulation of ceramide after infec-
tion, EOMA cells were infected with S. aureus (MOI 10:1) for
40 min, washed twice in PBS, and fixed with 1 % PFA in
buffered PBS (pH 7.3) for 15 min. The cells were then washed
in PBS, permeabilized for 10 min with 0.1 % Triton X-100 in
PBS, washed in PBS, blocked with an irrelevant affinity-
purified donkey antibody (Jackson; 1:100 in PBS+0.025 %
Tween 20) for 60 min at room temperature, washed three
times with PBS+0.025 % Tween 20, and incubated with a
rabbit anti-S. aureus antibody (Abcam 20920; 1:500 in PBS+
0.025 % Tween 20+5 % FCS) for 60 min at room tempera-
ture. The cells were then washed three times with PBS+
0.025 % Tween 20 and incubated with Alexa-Fluor 647-
coupled anti-rabbit Ig (Jackson; 1:500 in PBS+0.025 %
Tween 20+5 % FCS) overnight at 4 °C. The samples were
washed again three times, blocked again as above, washed
three times followed by a 60-min staining at room temperature
with mouse monoclonal anti-ceramide IgM (Glycobiotech
MAB 0011; 1:100 in PBS+0.025 % Tween 20+5 % FCS).
The samples were washed three times, stained with Cy3-
labeled anti-mouse IgM (Jackson; 1:500 in PBS+0.025 %
Tween 20+5% FCS) for 60 min at room temperature, washed
three times, and embedded in Mowiol (Kuraray Specialities
Europe GmbH, Frankfurt, Germany). The samples were ana-
lyzed by confocal microscopy using a Leica TCS SL micro-
scope (Leica, Mannheim, Germany).
Measurement of production of superoxide
Superoxide production was measured by electron spin reso-
nance (ESR), as described previously [31]. Then 2×105 en-
dothelial cells were infected with S. aureus for the indicated
time, the medium removed, the cells scraped into 20 mM
HEPES (pH 7.5), 1 mM EDTA, and 255 mM sucrose, and
shock frozen in liquid nitrogen. Proteins were isolated and
resuspended with modified Krebs-HEPES buffer containing
deferoximine (100 μM, Sigma) and diethyldithiocarbamate
(5 μM, Sigma). A spin trap, 1-hydroxy-3-methoxycarbonyl-2,
2,5,5-tetramethylpyrrolidine (CMH, Noxygen, Elzach,
Germany) (1 mM final concentration), was then added to the
mixture in the presence or absence of manganese-dependent
superoxide dismutase (SOD, 200 U/ml; Sigma, St. Louis,
MO). The mixture was loaded into glass capillaries and im-
mediately kinetically analyzed for O2
-. production for 10 min.
The SOD-inhibited fraction of the signal was used to calibrate
the system. The ESR settings were as follows: biofield, 3350;
field sweep, 60 G; microwave frequency, 9.78 GHz; micro-
wave power, 20 mW; modulation amplitude, 3 G; points of
resolution, 4096; receiver gain, 100; and kinetic time, 10 min.
The ESR signal strength was recorded in arbitrary units and
the final results were expressed as the fold changes compared
to the control.
Immunocytochemistry
Cells were grown on coverslips, infected or left uninfected,
fixed in 2 % paraformaldehyde (PFA, Sigma) buffered in PBS
(pH 7.2–7.4) for 10 min, and washed in PBS. For intracellular
staining of ZO1, ZO2, occludin, and E-cadherin, cells were
permeabilized with 0.1 % Triton X-100 (Sigma) in PBS
(pH 7.4) for 5 min at room temperature, washed with PBS,
and blocked for 1 h in PBS supplemented with 5 % fetal calf
serum (FCS, Gibco). Samples were washed and incubated
overnight at 4 °C with antibodies against ZO1 (Invitrogen
40-2300, rabbit IgG), ZO2 (Santa Cruz Biotechnology Inc.
sc-11448, rabbit IgG), occludin (71-1500, rabbit IgG,
Invitrogen), or E-cadherin (Santa Cruz Biotechnology
Inc. sc-7870, rabbit IgG). Cells were washed three times
in PBS with 0.05 % Tween 20 (Sigma), incubated for
1 h with Cy3-labeled donkey anti-rabbit antibodies, and
washed again in PBS with 0.05 % Tween 20. After a
final wash with PBS, cells were mounted on glass
coverslips with Mowiol. Cells were examined with a
Le ica TCS SP5 confoca l mic roscope (Le ica ,
Mannheim, Germany) using Leica software, version
2.61.
Histopathologic assessment
Mice were sacrificed, the lungs were removed, fixed in 4 %
PFA for 38 h, serially dehydrated, and embedded in paraffin
for sectioning at 6 μm. For stainings, sections were dewaxed
and rehydrated. H&E staining was performed by incubating
lung sections in hematoxylin for 2 min and in eosin for 1 min.
For fluorescence staining, lung sections were incubated in
pepsin (Invitrogen) for 20 min at 37 °C, washed, and treated
for 10 min in PBS supplemented with 5 % FCS and 0.5 %
Tween 20. Lung sections were exposed overnight at 4 °C to
anti-ZO1 IgG, anti-ZO2 IgG, anti-E-cadherin IgG, anti-
occludin IgG, or anti-Ly-6G and Ly-6C (Gr-1, rat IgG; BD)
antibodies (all antibodies as above). The sections were washed
in PBS with 0.05 % Tween 20 and then incubated for an
additional 45 min with Cy3-labeled secondary antibodies
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(Jackson ImmunoResearch, West Grove, PA, USA). For co-
stainings of TJs and endothelial cells, samples were incubated
together with antibodies against ZO1, ZO2, occludin, and E-
cadherin additionally with FITC-Lectin (Fluorescein Griffona
Simplicifolia Lectin I-Isolectin B4, Vector, FL-1201, 1:50) and
then proceeded as above. The sections were washed once in
PBS with 0.05 % Tween 20 and once in PBS and were
mounted in Mowiol. Lung samples were analyzed by light
transmission or confocal microscopy.
Quantification of S. aureus colony-forming units in liver,
spleen, and lung
To quantify S. aureus colony-forming units (CFU), we re-
moved the liver, spleen, and lung from each mouse after the
indicated time of infection and homogenized them in a loose
Dounce homogenizer (Braun, Germany). The homogenates
were lysed for 10 min in 5 mg/ml saponin (Serva
Electrophoresis GmbH, Heidelberg, Germany) at 37 °C for
the release of intracellular bacteria. Samples were centrifuged
for 10 min at 3200 rpm, resuspended in PBS, and plated on
lysogeny broth (LB) plates. Bacterial CFU were counted after
the plates had been incubated overnight at 37 °C.
Statistical analysis
All data are displayed as mean±SD. All data were tested for
normal distribution using the David–Pearson–Stephens test.
Statistical analysis was performed with Student’s t test for
single comparisons and ANOVA for multiple comparisons.
Groups in the survival tests were compared by log-rank test.
The sample size planning for the continuous in S. aureus
in vivo infections experiments was based on two-sided
Wilcoxon–Mann–Whitney tests using the free software
G*Power version 3.1.7 of the University of Dusseldorf,
Germany. Statistical significance was set at the level of P
<0.05.
Results
Acid sphingomyelinase deficiency reduces S. aureus–induced
lung edema
To determine whether Asm plays a role in the in vivo devel-
opment of lung edema caused by S. aureus infection, we
systemically infected C57BL/6 wild-type (wt) and Asm-
deficient mice with S. aureus for various time periods. To
quantify lung edema, we injected the dye Evans Blue, which
leaks into the lung only if the endothelial cell integrity is
disrupted and thereby serves to quantify lung edema in vivo.
The studies revealed massive leakage of Evans Blue dye into
the lungs of wt mice but almost no leakage into the lungs of
Asm-deficient mice after systemic infection with a clinical
S. aureus strain (Fig. 1a) or S. aureus Newman (supporting
Fig. 1A). Moreover, hematoxylin and eosin (H&E) staining of
the lungs demonstrated that S. aureus infection induces lung
edema in wt mice as indicated by thick hyaline walls in large
venules and massive cellular infiltrates, findings that were
absent or much less pronounced in Asm-deficient mice
(Fig. 1b and supporting Fig. 1B, C). The absence of lung
edema in Asm-deficient mice correlated with a reduced num-
ber of myeloid cells in the lungs of Asm-deficient mice, while
high numbers of GR1-positive, myeloid cells were observed
in the lungs of S. aureus–infected wt mice (Fig. 1c, d).
Controls revealed that Asm deficiency did not affect the
ability of myeloid cells to migrate (supporting Fig. 1D), but
reduced the production of superoxide in myeloid cells
(supporting Fig. 1E).
Taken together, these findings indicate that Asm plays a
key role in the development of pulmonary edema induced by
systemic infection with S. aureus. Asm deficiency inhibits the
development of lung injury during infection.
Infection of endothelial cells with S. aureus activates Asm
and leads to the production of superoxide in a positive
feedback loop
To further define the role of the Asm in lung edema induced
by systemic infections with S. aureus, we infected murine
endothelial (EOMA) cells with S. aureus and measured Asm
activity. S. aureus infection induced a marked activation of the
Asm (Fig. 2a and supporting Fig. 2A) and formation of
ceramide (Fig. 2b and supporting Fig. 2B), the product of
Asm activity.
Superoxide has long been known to play a crucial role in
host-pathogen interactions [20, 22, 23]. To determine whether
S. aureus infection also induces the release of superoxide and
whether this superoxide release depends on Asm, we infected
EOMA cells and analyzed the production of oxygen radicals.
The results showed that S. aureus infection induces a rapid
production of superoxide in EOMA cells (Fig. 2c and
supporting Fig. 2C). Infection with a lower multiplicity of
infection (MOI) of S. aureus revealed a similar but slightly
delayed time course of Asm activation (Fig. 2d), intracellular
ceramide accumulation at the site of S. aureus internalization
(Fig. 2e), and superoxide release (Fig. 2f). Pre-incubation of
EOMA cells with the antioxidants Tiron and N-acetylcysteine
(NAC) reduced Asm activation by S. aureus (Fig. 2d). Pre-
incubation of EOMA cells with the functional Asm inhibitor
amitriptyline (Ami) [17, 24, 26] or with Tiron and NAC also
inhibited superoxide release (Fig. 2c, f and supporting
Fig. 2C) suggesting a positive feedback loop of S. aureus–
induced Asm activation and superoxide release.
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S. aureus induces degradation of TJs via the Asm/ceramide
system
To gain insight into the mechanism by which Asm and cer-
amide mediate endothelial dysfunction and lung edema after
S. aureus infection, we determined whether systemic infection
with S. aureus induces the breakdown of TJs in pulmonary
endothelial cells in vivo and, if so, whether this process
depends on the Asm/ceramide system. To this end, we sys-
temically infected wt and Asm-deficient mice with S. aureus.
We then obtained lung sections and stained them with Cy3-
labeled antibodies to ZO1, ZO2, occludin, or E-cadherin.
Fig. 1 Acid sphingomyelinase deficiency protects against S. aureus–
induced lung edema. a Wild-type (wt) and acid sphingomyelinase
(Asm)-deficient mice were infected with S. aureus for 12 h. Evans Blue
dye was injected 30 min before sacrificing the mice and removal of the
lungs. The amount of dye leaking into the lung tissue was quantified.
Shown are the mean±SD of the concentration of Evans Blue dye in the
lungs from each five wt and Asm-deficient mice. *Significant differences
between uninfected mice and infected mice; #significant differences
between infectedwtmice and Asm-deficient mice (all P<0.05; ANOVA).
b Wt and Asm-deficient (Asm−/−) mice were infected with S. aureus for
the indicated time periods. They were sacrificed, and lung sections were
stained with H&E and analyzed by light microscopy for the detection of
lung edema. Scale bar is 100 μm. Representative images from three
independent experiments are shown. c, d For determination of pulmonary
myeloid cell influx, wt and Asm-deficient mice were left uninfected or
were infected with S. aureus for 12 or 24 h. Lung sections were stained
with Cy3-labeled anti-GR1 antibodies and analyzed by fluorescence
microscopy. Scale bar is 50 μm. Shown are representative images from
three independent experiments. Cells staining positive for GR1, a mye-
loid cell marker, were quantified by analysis of 50 fields per group.
Shown is the number (mean±SD) of GR1-positive cells using a 630-
fold magnification. *Significant differences between uninfected mice and
infected mice; #significant differences between infected wt mice and
Asm-deficient mice (all P<0.05; t test).
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Confocal microscopy showed that infection with S. aureus
induces dramatic degradation of TJ proteins in a time-
dependent manner in endothelial cells from blood vessels in
wt lungs but not in endothelial cells from the lungs of Asm-
deficient mice or wt mice pretreated with amitriptyline
(Fig. 3a–d and supporting Fig. 3A–H). Co-stainings of lung
sections with Cy3-coupled antibodies against TJs and FITC-
isolectin B4, which is a marker for endothelial cells, confirmed
that TJ proteins are only degraded in lung endothelial cells of
wt mice upon infection with S. aureus, but not in Asm-
deficient endothelial cells [25] (Fig. 3e, f and supporting
Fig. 4A–F).
Fig. 2 Asm is necessary for S. aureus–induced production of superoxide.
a, b Asm activity (a) and ceramide concentrations (b) were measured in
EOMA cells after infection with S. aureus for 0, 2, 5, or 10min at anMOI
of 200:1. Results show the mean±SD of three independent experiments.
*Significant differences compared to uninfected control mice (P<0.05, t
test). c EOMA cells were infected with S. aureus for 7.5 min at anMOI of
200:1. The production of superoxide was quantified by electron spin
resonance. Relative O2
-. levels were used to indicate superoxide
accumulation. Shown are means±SD from four independent
experiments. *Significant differences between uninfected samples and
infected samples; #significant differences between untreated samples and
amitriptyline (Ami)-treated samples (all P<0.05, ANOVA). d–f Infection
with a lower MOI (10:1) of S. aureus also resulted in Asm activation (d),
ceramide accumulation at the site of S. aureus infection (e), and
superoxide release (f). Pre-incubation of EOMA cells with the antioxi-
dants Tiron and N-acetylcysteine (NAC) (each 10 mM) reduced Asm
activation (d). Pre-incubation of EOMA cells with the functional Asm
inhibitor amitriptyline or with antioxidants also inhibited superoxide
release (f). Shown are means of arbitrary units±SD or representative
figures from four independent experiments. Scale bar is 10 μm. *Signif-
icant differences between uninfected samples and infected samples; #sig-
nificant differences between untreated and treated samples (all P<0.05,
ANOVA). Figures 3 and 4. S. aureus induces disruption of TJs in
endothelial cells via Asm-mediated superoxide production
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To determine whether TJs degradation pre-supposes the
production of superoxide, we pretreated wt mice with intra-
peritoneal injections of both Tiron or NAC and then infected
them with S. aureus. Confocal microscopy analysis demon-
strated that the inhibition of superoxide also protects TJ pro-
teins in endothelial cells from degradation after systemic
S. aureus infection in vivo (Fig. 3c, d and supporting
Fig. 3B, D, F, H). The in vivo findings were confirmed by
in vitro studies: infecting EOMA cells with S. aureus induces
a marked degradation of the TJ proteins ZO1, ZO2, occludin,
and E-cadherin, changes that were reduced by pre-incubation
with inhibition of the Asm by amitriptyline or superoxides by
NAC or Tiron (Fig. 4 and supporting Fig. 5A, B).
Collectively, these findings suggest that Asm mediates the
S. aureus–induced breakdown of TJ proteins by superoxide
in vivo.
Pharmacologic inhibition of Asm or superoxide reduces lung
edema after systemic infection with S. aureus
To test the significance of the pathway from the Asm
via superoxide to the degradation of TJ proteins and the
development of lung edema, we treated wt mice with
intraperitoneal injections of amitriptyline or the antioxi-
dants Tiron and NAC before systemic infection with
S. aureus and then measured lung edema and myeloid
cell influx after 12 h. S. aureus infection induced severe
lung edema and influx of myeloid cells into the lung,
events that were inhibited by pretreatment with amitrip-
tyline, Tiron or NAC (Fig. 5a–d). These findings show
that lung edema induced by S. aureus via the pathway
through Asm and superoxide can be reduced by pre-
treatment with pharmacologic inhibitors of this pathway.
Fig. 3 Wild-type (wt) and Asm-
deficient mice (Asm−/−) were left
uninfected or were infected with
S. aureus for the indicated time
points. Wt mice were pretreated
before infection with amitripty-
line (Ami) (10 mg/kg) or the an-
tioxidants Tiron (100 mg/kg) and
N-acetylcysteine (NAC)
(100 mg/kg), or left untreated
and/or uninfected. Lung sections
were stained with Cy3-coupled
antibodies against E-cadherin (a,
c) or co-stained for cadherin and
the endothelial cells marker
FITC-lectin (e, f) and analyzed by
confocal microscopy for determi-
nation of the degradation of these
TJ proteins. Representative im-
ages from three independent ex-
periments are shown [original
image and an area of interest
(AOI)]. Scale bar is 10 μm. To
score TJ protein fluorescence, we
focused on one large vessel, chose
the strongest fluorescence, and
analyzed signal intensity in ten
pictures per lung. The investiga-
tors were blinded to the identity of
the samples (b, d). *Significant
differences between uninfected
and infected samples; #significant
differences between wt and Asm-
deficient or untreated and treated
samples (all P<0.05, ANOVA).
682 J Mol Med (2015) 93:675–689
Treatment of already septic mice with amitriptyline reduces
the development of lung edema
The finding that both pre-incubation with the Asm inhibitor
amitriptyline and Asm deficiency protect mice from lung ede-
ma induced by S. aureus infection led us to question whether
the administration of amitriptyline reduces the severity of pul-
monary edema in mice that were already infected with
S. aureus. If so, amitriptyline administration might be a clini-
cally relevant therapeutic option for the treatment of
S. aureus–induced pulmonary edema. To this end, we infected
wt mice with S. aureus and treated them with amitriptyline
(Ami) 1 or 2 h later. The mice were sacrificed 12 h after
infection and Evans Blue extravasation into lung tissue was
determined or lung sections were stained with H&E. Treatment
with amitriptyline reduced the severity of pulmonary edema
and the influx of myeloid cells even after the onset of systemic
infection with S. aureus (Fig. 6a–d) and the breakdown of TJ
proteins (Fig. 6e, f and supporting Fig. 6A–D).
Thus, treatment with amitriptyline reduces the severity of
lung edema even when the drug is administered 1 or 2 h after
systemic infection with S. aureus.
The combination of amitriptyline and antibiotics inhibits
sepsis
Clinically, treating S. aureus sepsis with antibiotics achieves
only limited success, and severe lung edema often still develops
even with appropriate antibiotic treatment [27–29]. Thus, with
the aim of developing novel efficient therapeutic approaches to
the treatment of S. aureus–induced sepsis and lung edema, we
examined the effect of a combination of amitriptyline and
antibiotics on bacterial killing and lung edema after systemic
S. aureus infection. To this end, we infected wt mice with
S. aureus. With the incidence of first clinical symptoms 1 h
after infection, amitriptyline or methicillin or vancomycin or a
combination of amitriptyline and either methicillin or vanco-
mycin were injected. The injection of methicillin or vancomy-
cin was repeated after 9 h. Control mice were left uninfected.
The mice were sacrificed 24 h after infection, and bacterial
numbers were determined in liver, spleen, and lung.
While antibiotics alone or in combination with amitripty-
line kill bacteria in liver, spleen, and lung, neither methicillin
nor vancomycin alone reduced lung edema. In contrast, ami-
triptyline alone inhibited lung edema but did not reduce bac-
terial numbers. Only the combination of amitriptyline with
antibiotics reduced bacteremia, lung edema, pulmonary influx
of myeloid cells, and disruption of tight junctions (Fig. 7a–f;
supporting Fig. 7A–F; supporting Fig. 8A–G). Control studies
confirmed that the drugs were without effect on lung param-
eters in uninfected mice (supporting Fig. 9A–F).
These findings indicate that treating S. aureus infection
with a combination of amitriptyline and antibiotics might be
an effective clinical treatment for S. aureus–induced sepsis
because such treatment reduced both bacterial burden and
lung edema.
The pharmacological treatment of lung edema and bacterial
burden protects from lethality of S. aureus sepsis
To investigate the link between bacterial burden and sepsis-
induced lethality, we performed mortality experiments with
Fig. 4 Endothelial cells were
infected for 2 h with S. aureus
(MOI 10:1) or left uninfected. As
indicated, cells were pretreated
for 20 min with amitriptyline
(Ami) (20 μM), Tiron (10 mM),
or NAC (10 mM) before infection
with S. aureus. Immunofluores-
cence stainings were performed
with antibodies against ZO1,
ZO2, occludin, or E-cadherin for
determination of the degradation
of these TJ proteins. The present-
ed pictures are representative of
the results of at least three inde-
pendent experiments. Scale bar is
25 μm
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untreated and pharmacologically treated wt and Asm-deficient
mice after infecting them intravenously with 5×106 CFU
S. aureus. Wt mice died between 26 and 52 h after infection.
Treatment of wt mice with amitriptyline delayed the death of the
mice and the mice died between 50 and 85 h after infection. A
very similar time course was observed for Asm-deficient mice
that died between 50 and 80 h of infection. Treatment of wt mice
with methicillin or vancomycin (1 and 9 h after infection and
then twice daily) alone only rescued 50 % mice (11-day obser-
vation period). In contrast, the treatment of wt mice with a
combination of amitriptyline and antibiotics rescued 100 % of
infected wt mice, and no deaths were observed. Likewise, Asm-
deficient mice under antibiotic intervention were also completely
protected from sepsis-induced lethality (Fig. 8).
Next, we determined the number of bacteria in organs of
the mice. As shown above (Fig. 7a; supporting Fig. 8A), these
results showed lower bacterial numbers in liver, spleen, and
lung of wt mice compared to Asm-deficient mice 12 and 24 h
after infection.
In summary, these data indicate that the inhibition of lung
edema in Asm-deficient or amitriptyline-treated mice together
with a sufficient antibiotic treatment, which reduces the num-
ber of bacteria, but does not alter the effect of bacterial toxins
released during the infection or even after antibiotic treatment,
is able to completely protect from lethality of S. aureus sepsis.
Discussion
The results of the present study demonstrate that genetic
deficiency or pharmacologic inhibition of the Asm/ceramide
system protects against lung edema induced by systemic
S. aureus infection. A principal hallmark of lung edema is
degradation of TJ proteins, the disruption of endothelial cell
Fig. 5 Pharmacologic inhibition of acid sphingomyelinase (Asm) or
superoxide reduces pulmonary edema caused by systemic infection with
S. aureus. Wild-type (wt) mice were pretreated by intraperitoneal injec-
tion of 10 mg/kg amitriptyline (Ami) or 100 mg/kg Tiron/N-
acetylcysteine (NAC), respectively. Mice were infected with S. aureus
for 12 h. Lung edema was determined by extravasation of Evans Blue (a)
and by staining with H&E (scale bar is 100 μm) (b). Myeloid cell
emigration was determined by staining of lung sections with Cy3-
labeled anti-GR1 antibodies (scale bar is 50 μm) followed by fluores-
cence microscopy (c). Shown are representative images from three inde-
pendent experiments.Myeloid cell influxwas quantified by analysis of 50
fields per group (d). Displayed is the average of GR1-positive cells per
field using a 630-fold magnification. *Significant differences between
uninfected and infected samples; #significant differences between un-
treated and treated samples (all P<0.05, ANOVA).
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integrity, and a resultant increase in vascular permeability and
myeloid cell trafficking [6, 7]. All of these events are blocked
in vivo and in vitro by genetic deficiency of Asm or treatment
with the Asm inhibitor amitriptyline.
Our findings indicate that infection of endothelial cells with
S. aureus activates Asm and thereby triggers the release of
ceramide. Asm leads to the production of superoxide by endo-
thelial cells. On the other hand, Asm activation is reduced by
antioxidants, a result suggesting a positive feedback loop and a
vicious cycle of S. aureus–induced Asm activation and super-
oxide release. This finding is similar to the results of previous
studies showing a positive feedback loop between the Asm and
Fig. 6 Treatment of already infected mice with amitriptyline protects
against lung edema (a–d). Wild-type (wt) mice were infected with
S. aureus. Then 1 or 2 h later, they were i.p. injected with 16 mg/kg
amitriptyline (Ami). The mice were sacrificed 12 h after infection. The
lungs were removed and lung edema and myeloid cell trafficking were
determined by extravasation of Evans Blue (a), or staining with H&E
(scale bar is 100 μm) (b) or with Cy3-labeled anti-GR1 antibodies (scale
bar is 50 μm) (c). The average number of GR1-positive cells per field
using a 630-fold magnification was quantified by analysis of 50 fields per
group (d). The breakdown of TJs was analyzed by staining lung sections
with Cy3-labeled anti-E-cadherin antibodies (scale bar is 10 μm) (e).
Panel (a) shows the mean±SD from four mice. Images in (b), (c), and (e)
are representative from three independent experiments. TJ fluorescence
was scored via Photoshop (ten pictures per mouse) (f). Data in (d) and (f)
are shown as mean±SD, n=3. *Significant differences between uninfect-
ed and infected samples; #significant differences between treated and
untreated samples (all P<0.05, ANOVA).
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superoxide after infection of macrophages with P. aeruginosa
[30]. Recent studies showed that the translocation of lysosomal
V1 H+-ATPase to the plasma membrane in coronary artery
endothelial cells serves as a proton pump that contributes to
the formation of small acidic regions at the cell surface. This
shift in pH facilitates the activation of the Asm/ceramide system
and leads to the formation of redox signalosomes, in which
ceramide-enriched membrane domains are associated with the
enhanced NADPH oxidase–mediated production of O2
-. [31,
32]. A similar mechanism may apply to the activation of the
Asm by S. aureus on the cell surface. Recent studies revealed
that superoxide can directly downregulate TJ proteins and indi-
rectly activatematrixmetalloproteinases (MMPs) that contribute
to disrupt the integrity of endothelial cell layers. Moreover,
superoxide directly activates several inflammatory cytokines,
which in turn activate MMPs [33–35].
Fig. 7 The combination of amitriptyline and antibiotics cures S. aureus
sepsis and inhibits lung edema Wt mice were infected with S. aureus.
They were then left untreated, treated with an i.p. injection of
amitriptyline (Ami) (16 mg/kg) 1 h after infection, treated with either
methicillin (Methi) or vancomycin (Vanco) (both 100 mg/kg) 1 and 9 h
after infection, or treated with the combination of amitriptyline and
methicillin or vancomycin. The mice were sacrificed 24 h after
infection. a Lungs were removed, homogenized, and lysed in saponin
for the quantification of intracellular and extracellular bacteria (colony-
forming units, CFU) on lysogeny broth (LB) plates. Data shown aremean
±SD of three independent experiments from the lung; very similar data
were obtained for bacterial counts in the liver and spleen (not shown).
*Significant differences between uninfected and infected samples; #sig-
nificant differences between treated and untreated samples (P<0.05,
ANOVA). b Lungs from four mice per group were obtained after infec-
tion and subsequent treatment with the indicated drugs. Microscopic
analysis of lung sections stained either with H&E for lung edema (scale
bar is 100 μm), with Cy3-labeled anti-GR1 antibody for myeloid cell
trafficking (scale bar is 50 μm) (c), or for disruption of TJs with Cy3-
labeled anti-E-cadherin antibodies (e) (scale bar is 10 μm) was per-
formed. Shown are representative images from three independent exper-
iments by light transmission or confocal microscopy (b, c, e). The average
number of GR1-positive cells per field using a 630-fold magnification
was analyzed of 50 fields per group (d). TJ fluorescence was scored via
Photoshop (ten pictures per lung) (f). Data in (d) and (f) are shown as
mean±SD, n=3. *Significant differences between uninfected and infect-
ed samples; #significant differences between treated and untreated sam-
ples (all P<0.05, ANOVA).
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S. aureus is a leading cause of septic infections, and
S. aureus–induced sepsis is one of the most serious infections
acquired in hospitals or in the community. However, even
with the use of appropriate antibiotics, fatal lung edema often
develops [27–29]. Interestingly, our studies with wt and Asm-
deficient mice seem to mimic the situation in hospitals show-
ing a high lethality in septic S. aureus infections even if
adequately treated with antibiotics [27–29].
Our findings demonstrate that treating mice with amitripty-
line 1 or 2 h after infection reduces S. aureus–induced pulmo-
nary edema and also inhibits myeloid cell trafficking and the
degradation of TJ proteins. The reduced capacity of mice treated
with amitriptyline or Asm-deficient mice to kill S. aureus is
consistent with the previous notion that myeloid cells lacking
Asm are unable to cluster and activate NADPH oxidases
resulting in a defect of the production of superoxide and a
reduced killing of pathogens. Finally, amitriptyline-treated or
Asm-deficient mice died by the inability to eliminate the bacte-
ria. In contrast, antibiotics kill the bacteria, but did not reduce
lung edema. Thus, the combination of amitriptyline and antibi-
otics combines the advantages of inhibiting lung edema and
eliminating systemic bacteria, protecting mice from lethality.
These findings also suggest that the Asm is required to
mediate the effects of at least some S. aureus strains. S. aureus
expresses multiple toxins, such as alpha-toxin, Panton-
Valentine leukocidin, and enterotoxin B and A, which cause
membrane damage, infiltration of myeloid cells and macro-
phages, cytokine production, and increased vascular perme-
ability resulting in severe pulmonary edema and lung injury
[36–39]. Both of the S. aureus strains used in our study
produce several hemolysins. The pore-forming alpha-toxin,
which is one of the best-characterized virulence factors of
S. aureus, is involved in the pathogenesis of skin infections,
pneumonia, and sepsis, including those caused by MRSA. At
present, it is unknown whether purified alpha-toxin activates
the Asm in human and mouse monocytic cells. Recently, it
was reported that the binding of alpha-toxin to its eukaryotic
receptor A-disintegrin and metalloprotease 10 (ADAM10)
leads to the up-regulation of ADAM10 activity, which is
required for alpha-toxin-induced cytotoxicity [40–42].
Increased ADAM10 activity in epithelial and endothelial cells
disrupts the cell barrier function, and this disruption contrib-
utes to the pathogenesis of lethal lung edema. However, it is
unknown whether the Asm and ADAM10 function in the
same signaling cascade or are independent pathways that are
both required for the cellular effects of alpha-toxin.
Here, we demonstrated that the combination of amitripty-
line and antibiotics effectively protects mice from lung edema
and bacteremia during sepsis. Amitriptyline is a well-known
antidepressant that has been widely used in clinical practice
for more than 50 years and is associated with only mild
adverse effects at therapeutic doses. Thus, inhibition of the
Asm/ceramide system in combination with antibiotics could
be a novel approach to treat severe systemic and often lethal
infections and to inhibit lung injury in patients with incipient
sepsis.
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